SHSE:688050 (China)
Â
Class A
Â¥
88.50
(-1.97%)
Nov 28
Business Description
Eyebright Medical Technology (Beijing) Co Ltd
ISIN : CNE1000041J5
Share Class Description:
SHSE:688050: Class ACompare
Compare
Traded in other countries / regions
688050.China IPO Date
2020-07-29Description
Eyebright Medical Technology (Beijing) Co Ltd is engaged in research and development, production, sales and related services of ophthalmic medical devices. The company's product range includes Intraocular Lens; IOL Delivery System; Ophthalmic Instruments; Other Products; Literature; and Expert Interview.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.78 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.38 | |||||
| Interest Coverage | 21.18 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 13.42 | |||||
| Beneish M-Score | -1.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 43.4 | |||||
| 3-Year EBITDA Growth Rate | 36.6 | |||||
| 3-Year EPS without NRI Growth Rate | 39.9 | |||||
| 3-Year Book Growth Rate | 11.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 32.06 | |||||
| Future 3-5Y Total Revenue Growth Rate | 37.51 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.59 | |||||
| 9-Day RSI | 43.79 | |||||
| 14-Day RSI | 45.81 | |||||
| 6-1 Month Momentum % | 26.93 | |||||
| 12-1 Month Momentum % | -3.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.76 | |||||
| Quick Ratio | 3.76 | |||||
| Cash Ratio | 1.9 | |||||
| Days Inventory | 160.56 | |||||
| Days Sales Outstanding | 76.64 | |||||
| Days Payable | 40.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.54 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| Forward Dividend Yield % | 0.54 | |||||
| 5-Year Yield-on-Cost % | 0.58 | |||||
| Shareholder Yield % | -1.53 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.65 | |||||
| Operating Margin % | 32.1 | |||||
| Net Margin % | 27.21 | |||||
| FCF Margin % | -12.74 | |||||
| ROE % | 16.79 | |||||
| ROA % | 11.98 | |||||
| ROIC % | 15.4 | |||||
| ROC (Joel Greenblatt) % | 27.16 | |||||
| ROCE % | 15.42 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45.38 | |||||
| Forward PE Ratio | 32.57 | |||||
| PE Ratio without NRI | 44.16 | |||||
| Price-to-Owner-Earnings | 101.51 | |||||
| PEG Ratio | 1.01 | |||||
| PS Ratio | 12.35 | |||||
| PB Ratio | 7.2 | |||||
| Price-to-Tangible-Book | 8.79 | |||||
| Price-to-Operating-Cash-Flow | 56.19 | |||||
| EV-to-EBIT | 39.83 | |||||
| EV-to-EBITDA | 39.83 | |||||
| EV-to-Revenue | 12.69 | |||||
| EV-to-FCF | -94.28 | |||||
| Price-to-Projected-FCF | 13.72 | |||||
| Price-to-Graham-Number | 4.15 | |||||
| Price-to-Net-Current-Asset-Value | 163.89 | |||||
| Earnings Yield (Greenblatt) % | 2.51 | |||||
| FCF Yield % | -1.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eyebright Medical Technology (Beijing) Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,358.345 | ||
| EPS (TTM) (Â¥) | 1.95 | ||
| Beta | 1.31 | ||
| Volatility % | 55.15 | ||
| 14-Day RSI | 45.81 | ||
| 14-Day ATR (Â¥) | 5.302699 | ||
| 20-Day SMA (Â¥) | 95.272 | ||
| 12-1 Month Momentum % | -3.13 | ||
| 52-Week Range (Â¥) | 65.17 - 118 | ||
| Shares Outstanding (Mil) | 189.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eyebright Medical Technology (Beijing) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eyebright Medical Technology (Beijing) Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eyebright Medical Technology (Beijing) Co Ltd Frequently Asked Questions
What is Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050)'s stock price today?
The current price of SHSE:688050 is ¥88.50. The 52 week high of SHSE:688050 is ¥118.00 and 52 week low is ¥65.17.
When is next earnings date of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050)?
The next earnings date of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) is .
Does Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) pay dividends? If so, how much?
The Dividend Yield %  of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) is 0.54% (As of Today), Highest Dividend Payout Ratio of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) was 0.24. The lowest was 0.19. And the median was 0.19. The  Forward Dividend Yield % of Eyebright Medical Technology (Beijing) Co Ltd(SHSE:688050) is 0.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers